Ascendis Pharma A/S (NASDAQ:ASND) Q4 2025 Earnings Call Transcript

Ascendis Pharma A/S (NASDAQ:ASND) Q4 2025 Earnings Call Transcript February 11, 2026

Ascendis Pharma A/S misses on earnings expectations. Reported EPS is $-0.76815 EPS, expectations were $-0.06.

Operator: At this time, participants are in listen-only mode. Thank you for standing by, and welcome to the Ascendis Pharma A/S Fourth Quarter 2025 Earnings Conference Call. After the speakers’ presentation, there will be a question-and-answer session. To ask a question during this session, you...